Research on HIFU actually began in the 1950s
at Indiana University. In 1994, the first human prostate cancer
study was done by Dr. Marberger and Madersbacher at the Univ. of
Vienna in Austria using the Sonablate® 200 treating 29 human
prostates in vivo shortly before performing a radical prostatectomy.
The goal was to see if the energy delivered was enough to destroy
the desired tissue.
Study found that treatment could be performed safely and could be
repeated. In 1995, a study done at IU showed that the whole prostate
could be treated without damaging the prostate capsule or the rectal
wall. In 1999, Dr. Toyaki Uchida began treating patients using the
Sonablate® 200. In 2001, Sonablate® 500 receives CE mark
from Europe and the first patient in the study was treated at IU
by Dr. M. Koch. In 2004, USHIFU was created and has placed machines
in Canada, Mexico, Costa Rica, South Africa and the Caribbean. The
first Sonablate® 500 arrived to Puerto Vallarta on August, 2004,
the training and trials were done during 2004, using the system
to treat BPH and prostate cancer since 2005.
Currently there are nearly 100 Sonablate® 500 HIFU centers worldwide
on six continents. There are over 150 physicians using the Sonablate®
500 worldwide and over 5,000 total procedures have been completed
with the Sonablate®.
In the HIFU MX center in Puerto Vallarta, a total of 350 patients
have received treatment with HIFU.
How does HIFU work?